CERN developing mini particle accelerator for treatment of cancer

By  | 

Scientists at CERN, the European Organisation for Nuclear Research, in Switzerland are developing a new mini particle accelerator for application in medical field specifically for imaging and treatment of cancer.

The miniature linear accelerator (mini-Linac) will consist of four modules, each 50cm long, the first of which has already been constructed by scientists. Serge Mathot of the CERN engineering department revealed that post the construction of the first module, they have validated all the stages of construction and the concept in general.

The miniature accelerator is a radiofrequency quadrupole (RFQ), a component found at the start of all proton accelerator chains. RFQs are designed to produce high-intensity beams.


The challenge for the mini-Linac was to double the operating frequency of the RFQ in order to shorten its length. This desired high frequency had never before been achieved.

“Thanks to new beam dynamics and innovative ideas for the radio frequency and mechanical aspects, we came up with an accelerator design that was much better adapted to the practical requirements of medical applications,” said Alessandra Lombardi, in charge of the design of the RFQ.

The “mini-RFQ” can produce low-intensity beams, with no significant losses, of just a few microamps that are grouped at a frequency of 750 MHz. These specifications make the “mini-RFQ” a perfect injector for the new generation of high-frequency, compact linear accelerators used for the treatment of cancer with protons.

The accelerator’s small size and light weight mean that is can be set up in hospitals to produce radioactive isotopes for medical imaging. Producing isotopes on site solves the complicated issue of transporting radioactive materials and means that a wider range of isotopes can be produced.